Tapan Dilipkumar Patel, MD | |
31 Broadway Fl 2, North Haven, CT 06473-2363 | |
(203) 234-1324 | |
(203) 239-3047 |
Full Name | Tapan Dilipkumar Patel |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 9 Years |
Location | 31 Broadway Fl 2, North Haven, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225424252 | NPI | - | NPPES |
68709 | Other | CT | STATE OF CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 68709 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Yale-new Haven Hospital | New haven, CT | Hospital |
Mailing Address | Practice Location Address |
---|---|
Tapan Dilipkumar Patel, MD 31 Broadway Fl 2, North Haven, CT 06473-2363 Ph: (203) 234-1324 | Tapan Dilipkumar Patel, MD 31 Broadway Fl 2, North Haven, CT 06473-2363 Ph: (203) 234-1324 |
News Archive
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
Attending a brief diabetes education programme enhances the glycaemic control achieved by patients newly diagnosed, research suggests.
Insights from the study could change the way stroke is treated, extending the window for effective treatment from a couple of hours to a couple of weeks. The results may suggest new ideas for drug development.
A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.
Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.
› Verified 4 days ago
Dr. Thomas G Takoudes, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 31 Broadway, North Haven, CT 06473 Phone: 203-234-1324 Fax: 203-239-3047 | |
Dr. Agnes Czibulka, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 31 Broadway, North Haven, CT 06473 Phone: 203-234-1324 Fax: 203-239-3047 | |
Dr. Paul W Alberti, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 31 Broadway, North Haven, CT 06473 Phone: 203-234-1324 Fax: 203-239-3047 |